Novartis Ag (NVS) Income from Discontinued Operations (2013 - 2023)
Novartis Ag (NVS) posted Income from Discontinued Operations of $5.84 billion for Q4 2023, compared with $151 million a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) Income from Discontinued Operations (2013 - 2023) Analysis & Trends
For FY2023, Novartis Ag's Income from Discontinued Operations came in at $440 million, down 51.4% from FY2022.
- Annual Income from Discontinued Operations has declined for three consecutive years.
- In prior years, Novartis Ag's Income from Discontinued Operations was $906 million in FY2022 (-18.6%), $1.11 billion in FY2021 (-75.8%), $4.59 billion in FY2020 (unchanged) and $4.59 billion in FY2019.
- The Q4 2023 figure stands as the highest quarterly Income from Discontinued Operations since Q1 2015.
- According to Business Quant data, Income from Discontinued Operations for the three prior quarters was $250 million (Q3 2023), $46 million (Q2 2023) and $144 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | - |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | - |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | - |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 8.00 Mn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 5.84 Bn |
| Sep 30, 2023 | 250.00 Mn |
| Jun 30, 2023 | 46.00 Mn |
| Mar 31, 2023 | 144.00 Mn |
| Dec 31, 2022 | 151.00 Mn |
| Sep 30, 2022 | 245.00 Mn |
| Dec 31, 2019 | 741.00 Mn |
| Jun 30, 2019 | 4.69 Bn |
| Mar 31, 2019 | -101.00 Mn |
| Dec 31, 2018 | -26.00 Mn |
| Sep 30, 2018 | -258.00 Mn |
| Jun 30, 2018 | 40.00 Mn |
| Mar 31, 2018 | 13.00 Mn |
| Dec 31, 2015 | 2.00 Mn |
| Sep 30, 2015 | 83.00 Mn |
| Jun 30, 2015 | -18.00 Mn |
| Mar 31, 2015 | 10.70 Bn |
| Dec 31, 2014 | -961.00 Mn |
| Sep 30, 2014 | 1.71 Bn |
| Jun 30, 2014 | -138.00 Mn |
API Access
Novartis Ag Income from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-discontinued-operations", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();